Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yale Jiang

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Cancer Letters|June 2, 2024
Exosome-based anticancer vaccines: From Bench to bedsideGuo Zhao, Yuning Wang, Shujun Xing, et al.
Acta Pharmaceutica Sinica. B|December 23, 2022
Evolution of drug regulations and regulatory innovation for anticancer drugs in ChinaYang Liu, Ning Zhang, Cuicui Xie, et al.
The European Respiratory Journal|June 22, 2019
Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosisChristina Morse, Tracy Tabib, John Sembrat, et al.
Vaccines|July 27, 2022
Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine DevelopmentShuhang Wang, Yuqi Yang, Lu Li, et al.
The European Respiratory Journal|March 30, 2019
Transcriptomics of atopy and atopic asthma in white blood cells from children and adolescentsYale Jiang, Olena Gruzieva, Ting Wang, et al.
Nature Communications|April 11, 2019
A Bayesian mixture model for clustering droplet-based single-cell transcriptomic data from population studiesZhe Sun, Li Chen, Hongyi Xin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2025
Hantaan virus glycoprotein Gc induces NEDD4-dependent PTEN ubiquitination and degradation to escape the restriction of autophagosomes and facilitate viral propagationShuang Lu, Shuliang Chen, Yuqing Zhang, et al.
Frontiers of Medicine|May 15, 2023
Rare tumors: a blue ocean of investigationShuhang Wang, Peiwen Ma, Ning Jiang, et al.
Med (New York, N.Y.)|May 10, 2025
Learning from the LEAP trial series: Optimizing clinical trial design for combination therapiesJiatong Ding, Yue Yu, Dandan Cui, et al.
EMBO Molecular Medicine|November 28, 2022
Targeting rare tumors: new focus for clinical research in ChinaShuhang Wang, Yale Jiang, Huilei Miao, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Cancer Letters|June 2, 2024
Exosome-based anticancer vaccines: From Bench to bedsideGuo Zhao, Yuning Wang, Shujun Xing, et al.
Acta Pharmaceutica Sinica. B|December 23, 2022
Evolution of drug regulations and regulatory innovation for anticancer drugs in ChinaYang Liu, Ning Zhang, Cuicui Xie, et al.
The European Respiratory Journal|June 22, 2019
Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosisChristina Morse, Tracy Tabib, John Sembrat, et al.
Vaccines|July 27, 2022
Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine DevelopmentShuhang Wang, Yuqi Yang, Lu Li, et al.
The European Respiratory Journal|March 30, 2019
Transcriptomics of atopy and atopic asthma in white blood cells from children and adolescentsYale Jiang, Olena Gruzieva, Ting Wang, et al.
Nature Communications|April 11, 2019
A Bayesian mixture model for clustering droplet-based single-cell transcriptomic data from population studiesZhe Sun, Li Chen, Hongyi Xin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2025
Hantaan virus glycoprotein Gc induces NEDD4-dependent PTEN ubiquitination and degradation to escape the restriction of autophagosomes and facilitate viral propagationShuang Lu, Shuliang Chen, Yuqing Zhang, et al.
Frontiers of Medicine|May 15, 2023
Rare tumors: a blue ocean of investigationShuhang Wang, Peiwen Ma, Ning Jiang, et al.
Med (New York, N.Y.)|May 10, 2025
Learning from the LEAP trial series: Optimizing clinical trial design for combination therapiesJiatong Ding, Yue Yu, Dandan Cui, et al.
EMBO Molecular Medicine|November 28, 2022
Targeting rare tumors: new focus for clinical research in ChinaShuhang Wang, Yale Jiang, Huilei Miao, et al.
Pageof 4